A Single Dose of Cannabis Oil Reshapes the Sleeping Brain, Sydney Trial Finds

Plenty of people reach for cannabis when they cannot sleep, and many of them swear it works. The trouble is that "it works" usually means "I felt drowsy and drifted off," which is a report from the conscious mind about the moment before consciousness switches off. It says almost nothing about what the brain actually does for the seven or eight hours that follow. A new study set out to fill that gap by listening in.
Researchers at the University of Sydney and the Woolcock Institute of Medical Research, led by Anastasia Suraev, ran a small but unusually detailed experiment, published in the Journal of Sleep Research [2]. They recruited 20 adults who met the clinical criteria for insomnia disorder and brought each of them into the lab on separate nights. On one night a person swallowed an oil containing 10 mg of THC and 200 mg of CBD an hour before bed. On another night, at least a week apart, the same person took a placebo. Neither the participants nor the researchers knew which was which on any given night. That crossover design, where everyone serves as their own comparison, is one of the cleaner ways to study a drug, because it cancels out the enormous variation between one sleeper and the next.
What set the work apart was the recording. Instead of the handful of electrodes used in a standard sleep study, the team fitted each participant with a 256-channel high-density EEG cap — the same dense-electrode approach used to track how quickly meditation shifts brain activity. Think of it as the difference between a few microphones in a concert hall and a microphone over every seat. With that resolution you can ask not only whether someone reached deep sleep, but how the electrical rhythms of deep sleep differed region by region across the scalp.
So what did the cannabis oil do? The headline result is that it pulled the sleeping brain in several directions at once. Total sleep time shrank by roughly 25 minutes on the cannabis night [1]. REM sleep, the stage tied to vivid dreaming, took the biggest hit: it was cut by about 34 minutes, and its first appearance was pushed back by more than an hour [1]. During the lighter stages of sleep, the fast, high-frequency activity that can signal a restless, half-awake brain went down, which fits the calming reputation cannabis carries. Yet the slow waves of deep sleep, the rhythms most associated with physical and memory restoration, lost some of their intensity. And in the REM that remained, the back of the brain showed faster rhythms than usual, a pattern the authors read as a sign of heightened arousal sitting oddly inside the most relaxed-looking sleep stage.
Is that good or bad? The honest answer is that it depends on what you are measuring and why you care. Suppressed REM is the same effect produced by many antidepressants and by alcohol, and it is not automatically harmful in the short term. But REM rebound, the surge that can follow when a REM-suppressing substance is withdrawn, is a known phenomenon, and a single night cannot reveal whether it would happen here. The weaker slow-wave activity is harder to wave away, because deep sleep is doing real maintenance work while it happens.
There is a reassuring note in the daytime data. When participants were tested the next morning, their performance on cognitive and alertness tasks held up. They did report feeling a little sleepier subjectively, but that did not translate into measurable impairment on the tasks the researchers set. For anyone worried about a next-day hangover from a sleep aid, that is a meaningful, if narrow, finding.
The caveats here are not afterthoughts; they define how far the results can travel. Twenty people is a pilot, not a population, and a pilot in people with diagnosed insomnia may not describe what happens in the much larger group who use cannabis casually for sleep. Sleep disruption is also not the only cost of a disrupted schedule — shift workers show measurable volume loss in brain regions tied to emotion and alertness, a reminder of how broadly chronic sleep pressure registers in the brain. For more neuroscience coverage, see the full category. Every participant got one dose, on one night, of one fixed THC-to-CBD ratio. The products sold in dispensaries and pharmacies vary wildly in their cannabinoid content and delivery, so the numbers from this oil should not be mapped onto a gummy or a vape. The lab also held everyone to a fixed eight-hour sleep window, which is tidy for science but may have hidden the natural ways a brain catches up after a disrupted night. Crucially, nothing in a one-night study can speak to tolerance, dependence, or what weeks of nightly use would do. Those are the questions most users actually have, and they remain open.
What this work does well is separate two things that often get blurred. Falling asleep faster and feeling rested is one outcome. The architecture of the night, the orderly cycling through light, deep, and dreaming sleep that the brain seems to need, is another. A single dose of this cannabis oil appeared to help with the first while quietly rearranging the second. Whether that trade is worth making is a question this study raises rather than settles, and it is a better question than the one most people start with.
Sources
- Suraev, A., McGregor, I. S., McCartney, D., Marshall, N. S., Kao, C.-H., Wassing, R., D'Rozario, A. L., Wong, K. K. H., Yee, B. J., Sivam, S., Kevin, R. C., Vandrey, R., Irwin, C., Gordon, C. J., Bartlett, D., Arnold, J. C., Grunstein, R. R., & Hoyos, C. M. (2026). Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial. Journal of Sleep Research. https://doi.org/10.1111/jsr.70124
- National Library of Medicine. (2026). Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial. https://pubmed.ncbi.nlm.nih.gov/40631525/
This article summarizes published research for general informational purposes only. It is not medical advice and should not be used to guide treatment, diagnosis, or other health decisions. Speak with a qualified healthcare professional about any health concern.
Frequently asked questions
- How many people took part in the Sydney cannabis sleep trial?
- Twenty adults with diagnosed insomnia disorder participated. Each person received both the cannabis oil and a placebo on separate nights at least a week apart, in a double-blind crossover design, so everyone served as their own comparison.
- What happened to REM sleep after the cannabis oil dose?
- REM sleep was reduced by about 34 minutes, and its first appearance was delayed by more than an hour compared with the placebo night. The back of the brain also showed faster-than-usual rhythms during the REM that did occur, which the authors interpreted as a sign of heightened arousal within that stage.
- Did the cannabis oil impair thinking or alertness the next morning?
- Participants reported feeling somewhat sleepier, but performance on cognitive and alertness tasks the next morning did not show measurable impairment. The authors note this is a narrow finding from a single-dose, one-night study and cannot speak to longer-term or repeated use.
Comments (6)
Daniel
Months of CBD tincture and I never once asked myself what I was actually measuring — falling asleep faster, or the architecture of the whole night. The distinction didn't feel important until I read this. Now I'm genuinely uncertain which problem I've been solving.
Priya
The 'no measurable next-day impairment' finding deserves more scrutiny than the article gives it. Twenty people, one night, a fixed battery of alertness tasks chosen by the researchers — that's a narrow net. Emotional flatness and motivational drag don't show up in standard cognitive testing. The 256-channel EEG methodology is legitimately rigorous, but that one reassurance feels overstated.
Marcos
I used cannabis heavily in my mid-twenties specifically to stop dreaming. Vivid, exhausting nightmares every night, and it was the only thing that worked. When I quit, the dreams came back so intensely for several weeks that I went to a GP convinced something was neurologically wrong with me. Nobody mentioned REM rebound. Nobody said withdrawal was even a category. Reading that section, years later, the whole episode finally has a name.